Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05KXF
|
|||
| Drug Name |
Tetra-hydro-naphthyridine derivative 1
|
|||
| Synonyms |
PMID26413912-Compound-80
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
RENOVIS, INC. KELLY, Michael, G. KINCAID, John GOWLUGARI, Sumithra KAUB, Carl
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H22N4
|
|||
| Canonical SMILES |
C1CN(CC2=C1C(=NC=C2)NC3=CC4=CC=CC=C4N=C3)CC5=CC=CC=C5
|
|||
| InChI |
1S/C24H22N4/c1-2-6-18(7-3-1)16-28-13-11-22-20(17-28)10-12-25-24(22)27-21-14-19-8-4-5-9-23(19)26-15-21/h1-10,12,14-15H,11,13,16-17H2,(H,25,27)
|
|||
| InChIKey |
WVIVDSQVVHCZNX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.